Results 191 to 200 of about 85,932 (276)

A Rare Case of P‐Null Phenotype Identified During Preoperative Screening

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT A 46‐year‐old woman scheduled for an elective total abdominal hysterectomy was incidentally found to have a rare P‐null (p) phenotype during routine preoperative testing. Although her ABO/Rh type was A positive, the antibody screen demonstrated strong pan‐reactivity with all panel cells, while the autocontrol was negative, indicating an ...
Alireza Abdollahi   +3 more
wiley   +1 more source

Cardiorespiratory and Hematological Responses to High‐Intensity Interval Training in Adolescent Girls With Overweight or Obesity: A Randomized Controlled Trial

open access: yesEuropean Journal of Sport Science, Volume 26, Issue 5, May 2026.
ABSTRACT This randomized controlled trial examined the effects of a 10‐week high‐intensity interval training (HIIT) program on physiological and hematological outcomes in 28 adolescent girls with overweight or obesity. Participants were randomly assigned to a HIIT group or a control group. The HIIT protocol comprised 4 sets of 6 × 15‐s bouts at 90%–105%
Wissal Abassi   +6 more
wiley   +1 more source

In vivo modeling of stress erythropoiesis through targeted gene editing of rat hematopoietic stem cells. [PDF]

open access: yesBlood Adv
van der Meulen SA   +4 more
europepmc   +1 more source

The impact of low‐dose aspirin on hemoglobin levels in pregnancy: A secondary analysis of a randomized controlled trial for prevention of hypertensive disorders of pregnancy

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 173, Issue 2, Page 982-988, May 2026.
Abstract Objectives This study evaluates the association of low‐dose aspirin (LDA) with hemoglobin (Hb) levels during pregnancy and explores how changes in Hb levels relate to hypertensive disorders of pregnancy (HDP). Methods This secondary analysis of a randomized controlled trial comprised 249 pregnant women recruited from a regional hospital in ...
N. M. Ngcobo   +4 more
wiley   +1 more source

UBE2O as a key regulator of drug-induced erythropoiesis in the context of myelodysplastic syndromes. [PDF]

open access: yesBlood Adv
Maffeo B   +12 more
europepmc   +1 more source

The Effect of Iclepertin on Hematological Parameters: An Overview of Nonclinical Studies and Clinical Trials in Healthy Volunteers and Patients with Cognitive Impairment Associated with Schizophrenia

open access: yesThe Journal of Clinical Pharmacology, Volume 66, Issue 5, May 2026.
Abstract There are currently no approved pharmacotherapies to treat cognitive impairment associated with schizophrenia (CIAS). Iclepertin (BI 425809) is a selective glycine transporter‐1 (GlyT1) inhibitor that was investigated for the treatment of CIAS.
Peter Nagy   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy